Navigation Links
AACR, BCRF award inaugural grants in translational breast cancer research
Date:10/11/2007

t protocols swiftly, safely and effectively.

Fifty-six grant applications were received and resulted in three awards, each for $233,333, to support promising research projects that could lead to individualized therapeutic options for breast cancer treatment in the near future.

Mayers research project, titled Combined Endocrine and ErbB Inhibition in ER+/HER2+ Breast Cancers, will address resistance to endocrine therapies. Through a Phase II study, she seeks to learn if the combination of an aromatase inhibitor with an EGFR/HER2 inhibitor will work better in preventing failure of tumors to respond to anti-hormonal treatment. Mayer hopes that her research will reduce mortality in patients with hormone-responsive HER2-positive breast cancer.

Welms research, The MSP Pathway as a Therapeutic Target in Aggressive Breast Cancer, will build upon her earlier studies which found that overexpression of the macrophage- stimulating protein (MSP) pathway drives progression of breast cancer. She validated the clinical relevance of this finding through gene expression data gathered from patients with early- stage breast cancer, showing that overexpression of three genes within the MSP pathway served as highly accurate indicators of poor prognosis in patients with early breast cancer. Her current research seeks to translate these findings to the clinic by developing a diagnostic test for overexpression of the MSP pathway as a biomarker for poor prognosis and to carry out preclinical tests of three MSP pathway inhibitors in order to block growth and/or metastasis of breast cancer.

Yee will look at Gene Expression Profiling to Predict Response to anti-IGF Therapy. This research builds upon his long-term goal of demonstrating that the insulin-like growth factor receptor (IGF1R) is an excellent target for breast cancer therapy. Yee hypothesizes that expression of specific insulin receptor substrate adaptor proteins link IGF1R to identifiable
'/>"/>

Contact: Jennifer Ryan
jennifer.ryan@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. NJIT Presidential Award winner takes stem cell research another step
2. TGen awarded $7.1 million to accelerate brain disease research
3. Virtual microscopy project wins educational technology award
4. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
5. Asian immigrants in NYC not receiving HIV education at religious institutions
6. Scientists win grants to develop $1,000 genome sequencing technology
7. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
8. A splice of the action: Translational role for WT1 isoform
9. Viral DNA sequence a possible trigger for breast cancer
10. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
11. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... emerging as a world-famous vacation spot with natural tourism resources, ... island. The Korea Institute of Geoscience and Mineral Resources (KIGAM) ... recent volcanic eruption was evident 5,000 years ago. That is ... lava spewed out of a volcano 5,000 years ago in ... one the whole peninsula. , The research team led by ...
(Date:7/22/2014)... is known about the the genus of planthopper known ... new one was recently discovered in the southern part ... Jaen. A description of it appears in the open-access ... ). , The new species, Conosimus baenai , ... for his contributions to the taxonomy of Iberian Hemiptera. ...
(Date:7/21/2014)... Their scruffy beards weren,t ironic, but there are reasons ... the Ice Age. , According to research from the ... liked living in Greater Cincinnati long before it was ... age. A study led by Brooke Crowley, an assistant ... enjoyed the area so much they likely were year-round ...
Breaking Biology News(10 mins):Jeju Island is a live volcano 2Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3
... scientist from The Scripps Research Institute has identified a new ... formation. The molecule could become a target for the development ... as Hemophilia A. The findings, from a study by ... a recent edition of Journal of Biological Chemistry . ...
... Avantra Biosciences (Avantra) today announced the selection ... test site for Avantra,s new biomarker quantitation platform. ... has created an automated multiplex immunoassay system to ... patient characteristics, and drug responses. The new Q400 ...
... - A Purdue University scientist has found genetic evidence of ... finding he believes could one day be used to help ... Salt, a professor of horticulture, noticed several years ago that ... tolerate higher levels of sodium had come from coastal areas. ...
Cached Biology News:Scripps Research scientist discovers natural molecule indirectly prevents stable clot formation 2Scripps Research scientist discovers natural molecule indirectly prevents stable clot formation 3Avantra Biosciences teams with TGen Drug Development to assist pharma 2Plants can adapt genetically to survive harsh environments 2
(Date:7/22/2014)... Massachusetts og SHENZHEN ... Tech Solutions Co., LTD, (BGI Tech), et datterselskab ... lancering af en ny human whole exome-sekvenseringstjeneste baseret ... Complete Genomics, højt anset i branchen for at ... højfølsom registrering af alle typer varianter, blev købt ...
(Date:7/22/2014)... Switzerland (PRWEB) July 22, 2014 ... are becoming an increasingly common sight. The rapid ... they are now well- established as a core ... low maintenance has made them the gas analyzer ... locations and conditions encountered in some processes have ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Holomic ... with the debut of its fluorescent immunoassay reader, ... Chemistry (AACC) meeting in Chicago, July 28-31, 2014. ... top versions, the HRDR-300 is a highly sensitive, ... to analyze fluorescent lateral flow immunoassays with high ...
(Date:7/21/2014)... 21, 2014 Lawrence Livermore ... Board (WIB) and Las Positas College (LPC) recently ... education and hands-on training for veterans, officials recently ... at Las Positas is designed to help ... engineering technician careers, and establishes a pipeline of ...
Breaking Biology Technology:BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3
... on August 21 and Roth Capital,s 2007 New York ... ... Strategic Diagnostics,Inc. (Nasdaq: SDIX ) -- a leading ... water, agricultural, environmental and,life science applications, announced today that its ...
... BioMaxx Systems Inc. (Other,OTC: BMXSF), is pleased ... with,Alcofuel Technologies Ltd., for the provision of the ... to the engagement,letter, Alcofuel Technologies has agreed, subject ... to design and manufacture a small,scale ethanol micro-refinery ...
... Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceutical ... product candidates for the treatment,of cancer and ... Food and,Drug Administration (FDA) has granted fast ... is currently being investigated in a,pivotal Phase ...
Cached Biology Technology:Strategic Diagnostics to Present at Two Upcoming Investor Conferences 2Strategic Diagnostics to Present at Two Upcoming Investor Conferences 3Strategic Diagnostics to Present at Two Upcoming Investor Conferences 4Strategic Diagnostics to Present at Two Upcoming Investor Conferences 5BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 3